{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:00:04Z","timestamp":1781632804397,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"the Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["18H00431"],"award-info":[{"award-number":["18H00431"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Breastfeed J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tacrolimus is a calcineurin inhibitor immunosuppressant widely used in organ transplantation and the management of autoimmune diseases. Tacrolimus is generally considered to be safe for women who are breastfeeding; however, pharmacokinetic differences related to genetic background have been reported, and clinical data focusing on Japanese women during lactation remain scarce. As such, this study evaluated the safety of tacrolimus in Japanese women diagnosed with autoimmune diseases during breastfeeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This exploratory retrospective analysis was conducted at a single tertiary care hospital in Japan. Participants were divided into 2 groups: breastfeeding mothers prescribed tacrolimus (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096); and breastfeeding mothers who did not receive tacrolimus (control group;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912). Most infants were primarily breastfed. Between January 2011 and June 2018, maternal characteristics and adverse events in infants from birth to the 1-month checkup were collected from medical records and \u201cplan-sheets for lactation\u201d completed at approximately 28 weeks\u2019 gestation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All mothers in the tacrolimus group received a daily tacrolimus dose of 3\u00a0mg throughout the observation period. The adverse events observed in the tacrolimus group included jaundice (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20095), rashes (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093), vomiting (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093), head hematoma (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092), minor skin lesion (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091), and respiratory failure (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091). All adverse events were non-serious and the infants recovered uneventfully. The Isobe Neonatal Withdrawal Syndrome score was 0 in all evaluated infants in the tacrolimus group during the first month after birth. All 6 mother-infant pairs in the tacrolimus group continued breastfeeding and maternal medication through the 1-month postpartum checkup. A significantly higher incidence of vomiting was observed in the tacrolimus group compared with the control group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Preliminary observations in this small Japanese cohort revealed no serious adverse events in breastfed infants during the first month, but larger studies are required to confirm safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13006-026-00820-1","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:35:40Z","timestamp":1770467740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety of tacrolimus during lactation: an exploratory retrospective analysis in a small Japanese cohort"],"prefix":"10.1186","volume":"21","author":[{"given":"Kazushi","family":"Yashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Obara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeko","family":"Hosono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoi","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Hoshiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takushi","family":"Hanita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariyasu","family":"Mano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"2","key":"820_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.rdc.2007.01.002","volume":"33","author":"ME Clowse","year":"2007","unstructured":"Clowse ME. Lupus activity in pregnancy. Rheum Dis Clin North Am. 2007;33(2):237\u2013. https:\/\/doi.org\/10.1016\/j.rdc.2007.01.002. \u200952.","journal-title":"Rheum Dis Clin North Am"},{"key":"820_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bpobgyn.2019.09.002","volume":"64","author":"M Petri","year":"2020","unstructured":"Petri M. Pregnancy and systemic lupus erythematosus. Best Pract Res Clin Obstet Gynaecol. 2020;64:24\u201330. https:\/\/doi.org\/10.1016\/j.bpobgyn.2019.09.002.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"820_CR3","unstructured":"Astellas Pharma Inc. Prograf Capsules (tacrolimus) [package insert]. (in Japanese). https:\/\/www.info.pmda.go.jp\/go\/pack\/3999014M1022_3_40\/?view=frame&style=XML&lang=ja (accessed 22 Jun 2025)."},{"key":"820_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1365-2125.2008.03162.x","volume":"66","author":"Y Suzuki","year":"2008","unstructured":"Suzuki Y, Homma M, Doki K, Itagaki F, Kohda Y. Impact of CYP3A5 genetic polymorphism on pharmacokinetics of tacrolimus in healthy Japanese subjects. Br J Clin Pharmacol. 2008;66:154\u20135. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03162.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"820_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2131\/jts.47.71","volume":"47","author":"T Hirai","year":"2022","unstructured":"Hirai T, Morikawa Y, Sasaki N, Kato H, Nakato D, Hirayama M, et al. Pharmacokinetics of tacrolimus following an overdose in a patient with extreme obesity and genotype CYP3A5*3\/*3: a case report. J Toxicol Sci. 2022;47(2):71\u20135. https:\/\/doi.org\/10.2131\/jts.47.71.","journal-title":"J Toxicol Sci"},{"issue":"3","key":"820_CR6","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3390\/ijms19030882","volume":"19","author":"H Kagaya","year":"2018","unstructured":"Kagaya H, Niioka T, Saito M, Inoue T, Numakura K, Yamamoto R, et al. Prediction of tacrolimus exposure by CYP3A5 genotype and exposure of co-administered everolimus in Japanese renal transplant recipients. Int J Mol Sci. 2018;19(3):882. https:\/\/doi.org\/10.3390\/ijms19030882.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"820_CR7","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1111\/bcp.13952","volume":"85","author":"Z Lu","year":"2019","unstructured":"Lu Z, Bonate P, Keirns J. Population pharmacokinetics of immediate- and prolonged-release tacrolimus formulations in liver, kidney and heart transplant recipients. Br J Clin Pharmacol. 2019;85(8):1692\u2013703. https:\/\/doi.org\/10.1111\/bcp.13952.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"820_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/biomedicines8040094","volume":"8","author":"M Saiz-Rodr\u00edguez","year":"2020","unstructured":"Saiz-Rodr\u00edguez M, Almenara S, Navares-G\u00f3mez M, Ochoa D, Rom\u00e1n M, Zubiaur P, et al. Effect of the most relevant CYP3A4 and CYP3A5 polymorphisms on the Pharmacokinetic parameters of 10 CYP3A substrates. Biomedicines. 2020;8(4):94. https:\/\/doi.org\/10.3390\/biomedicines8040094.","journal-title":"Biomedicines"},{"issue":"6","key":"820_CR9","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/ajcn\/nqz229","volume":"110","author":"K Miliku","year":"2019","unstructured":"Miliku K, Duan QL, Moraes TJ, Becker AB, Mandhane PJ, Turvey SE, et al. Human milk fatty acid composition is associated with dietary, genetic, sociodemographic, and environmental factors in the CHILD cohort study. Am J Clin Nutr. 2019;110(6):1370\u201383. https:\/\/doi.org\/10.1093\/ajcn\/nqz229.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"820_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/npm-230138","volume":"16","author":"K Yashima","year":"2023","unstructured":"Yashima K, Noda A, Ishikawa T, Matsuzaki F, Miyakoda K, Nishigori H, et al. Safety evaluation of the use of calcineurin inhibitor to prenatal and postpartum women in Japan from a health administrative database. J Neonatal Perinat Med. 2023;16(3):461\u20133. https:\/\/doi.org\/10.3233\/npm-230138.","journal-title":"J Neonatal Perinat Med"},{"issue":"4","key":"820_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1248\/yakushi.20-00184","volume":"141","author":"T Obara","year":"2021","unstructured":"Obara T. Study on the safety of perinatal medication. J Pharm Soc Jpn. 2021;141(4):463\u2013. https:\/\/doi.org\/10.1248\/yakushi.20-00184. \u200971.","journal-title":"J Pharm Soc Jpn"},{"issue":"5","key":"820_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1089\/bfm.2020.0210","volume":"16","author":"K Yashima","year":"2021","unstructured":"Yashima K, Obara T, Matsuzaki F, Suzuki C, Saeki M, Koyama M, et al. Evaluation of the safety of taking lamotrigine during lactation period. Breastfeed Med. 2021;16(5):432\u20138. https:\/\/doi.org\/10.1089\/bfm.2020.0210.","journal-title":"Breastfeed Med"},{"key":"820_CR13","volume-title":"Medications and mothers\u2019 milk","author":"TW Hale","year":"2025","unstructured":"Hale TW. Medications and mothers\u2019 milk. 21st ed. New York: Springer Publishing Company; 2025.","edition":"21"},{"key":"820_CR14","volume-title":"Drugs in pregnancy and lactation","author":"GG Briggs","year":"2022","unstructured":"Briggs GG, Freeman RK, Towers CV, Forinash AB. Drugs in pregnancy and lactation. 12th ed. Philadelphia: Wolters Kluwer; 2022.","edition":"12"},{"key":"820_CR15","unstructured":"Isobe K, Ishii M, Kusaka T. Jun. Research on systemic care system for a high risk child management of newborn babies with the withdrawal syndrome. Questionnaire survey on evaluation method by a check list and score table. https:\/\/www.niph.go.jp\/wadai\/mhlw\/1994\/h061142.pdf (accessed 22 2025)."},{"issue":"1\u20132","key":"820_CR16","first-page":"141","volume":"2","author":"LP Finnegan","year":"1975","unstructured":"Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2(1\u20132):141\u201358.","journal-title":"Addict Dis"},{"key":"820_CR17","unstructured":"Japan Society of Obstetrics and Gynecology. Japan Association of Obstetricians and Gynecologists. Guideline for Gynecological Practice in Japan 2020. https:\/\/www.jsog.or.jp\/activity\/pdf\/gl_sanka_2023.pdf (accessed 13 Jan 2025)."},{"issue":"1","key":"820_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1620\/tjem.234.51","volume":"234","author":"Y Izumi","year":"2014","unstructured":"Izumi Y, Miyashita T, Migita K. Safety of tacrolimus treatment during pregnancy and lactation in systemic lupus erythematosus: a report of two patients. Tohoku J Exp Med. 2014;234(1):51\u20136. https:\/\/doi.org\/10.1620\/tjem.234.51.","journal-title":"Tohoku J Exp Med"},{"issue":"14","key":"820_CR19","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1177\/0961203318809178","volume":"27","author":"Y Hiramatsu","year":"2018","unstructured":"Hiramatsu Y, Yoshida S, Kotani T, Nakamura E, Kimura Y, Fujita D, et al. Changes in the blood level, efficacy, and safety of tacrolimus in pregnancy and the lactation period in patients with systemic lupus erythematosus. Lupus. 2018;27(14):2245\u201352. https:\/\/doi.org\/10.1177\/0961203318809178.","journal-title":"Lupus"},{"key":"820_CR20","unstructured":"The Japanese Ministry of Health, Labour and Welfare. Jinko dotai tokei tokushu hokoku shussei ni kansuru tokei (Vital statistics special report on birth). 2010. https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/tokusyu\/syussyo06\/syussyo2.html#05 (accessed 22 Jun 2025)."},{"issue":"11","key":"820_CR21","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.2215\/cjn.00240110","volume":"5","author":"A Smyth","year":"2010","unstructured":"Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5(11):2060\u20138. https:\/\/doi.org\/10.2215\/cjn.00240110.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"820_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5001\/omj.2018.04","volume":"33","author":"R Abdwani","year":"2018","unstructured":"Abdwani R, Al Shaqsi L, Al-Zakwani I. Neonatal and obstetrical outcomes of pregnancies in systemic lupus erythematosus. Oman Med J. 2018;33(1):15\u201321. https:\/\/doi.org\/10.5001\/omj.2018.04.","journal-title":"Oman Med J"},{"issue":"4","key":"820_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00007890-199708270-00002","volume":"64","author":"A Jain","year":"1997","unstructured":"Jain A, Venkataramanan R, Fung JJ, Gartner JC, Lever J, Balan V, et al. Pregnancy after liver transplantation under tacrolimus. Transplantation. 1997;64(4):559\u201365. https:\/\/doi.org\/10.1097\/00007890-199708270-00002.","journal-title":"Transplantation"},{"issue":"1","key":"820_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.transproceed.2005.12.044","volume":"38","author":"Z Jabiry-Zieniewicz","year":"2006","unstructured":"Jabiry-Zieniewicz Z, Kami\u0144ski P, Pietrzak B, Cyganek A, Bobrowska K, Zi\u00f3\u0142kowski J, et al. Outcome of four high-risk pregnancies in female liver transplant recipients on tacrolimus immunosuppression. Transpl Proc. 2006;38(1):255\u20137. https:\/\/doi.org\/10.1016\/j.transproceed.2005.12.044.","journal-title":"Transpl Proc"},{"issue":"1","key":"820_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/ije\/dyz169","volume":"49","author":"S Kuriyama","year":"2020","unstructured":"Kuriyama S, Metoki H, Kikuya M, Obara T, Ishikuro M, Yamanaka C, et al. Cohort profile: Tohoku medical megabank project birth and three-generation cohort study (TMM birthree cohort Study): rationale, progress and perspective. Int J Epidemiol. 2020;49(1):18\u20139. https:\/\/doi.org\/10.1093\/ije\/dyz169.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"820_CR26","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1111\/apa.12587","volume":"103","author":"N Kato","year":"2014","unstructured":"Kato N, Takimoto H, Yokoyama T, Yokoya S, Tanaka T, Tada H. Updated Japanese growth references for infants and preschool children, based on historical, ethnic and environmental characteristics. Acta Paediatr. 2014;103(6):e251\u20137. https:\/\/doi.org\/10.1111\/apa.12587.","journal-title":"Acta Paediatr"},{"issue":"1","key":"820_CR27","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1542\/peds.2007-1107","volume":"121","author":"JJ Henderson","year":"2008","unstructured":"Henderson JJ, Hartmann PE, Newnham JP, Simmer K. Effect of preterm birth and antenatal corticosteroid treatment on lactogenesis II in women. Pediatrics. 2008;121(1):e92\u2013100. https:\/\/doi.org\/10.1542\/peds.2007-1107.","journal-title":"Pediatrics"},{"issue":"8","key":"820_CR28","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/biology10080709","volume":"10","author":"D Szypulska-Koziarska","year":"2021","unstructured":"Szypulska-Koziarska D, Wilk A, Marchelek-My\u015bliwiec M, \u015aleboda-Taront D, Wiszniewska B. Tacrolimus-based immunosuppressive therapy influences sex hormone profile in renal-transplant recipients: a research study. Biology (Basel). 2021;10(8):709. https:\/\/doi.org\/10.3390\/biology10080709.","journal-title":"Biology (Basel)"},{"issue":"1","key":"820_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0002-9378(75)90978-3","volume":"121","author":"T Horiguchi","year":"1975","unstructured":"Horiguchi T, Bauer C. Ethnic differences in neonatal jaundice: comparison of Japanese and Caucasian newborn infants. Am J Obstet Gynecol. 1975;121(1):71\u20134. https:\/\/doi.org\/10.1016\/0002-9378(75)90978-3.","journal-title":"Am J Obstet Gynecol"},{"key":"820_CR30","doi-asserted-by":"publisher","first-page":"321359","DOI":"10.1155\/2014\/321359","volume":"2014","author":"E Cozzani","year":"2014","unstructured":"Cozzani E, Drosera M, Gasparini G, Parodi A. Autoimmune diseases and pregnancy. Autoimmune Dis. 2014;2014:321359. https:\/\/doi.org\/10.1155\/2014\/321359.","journal-title":"Autoimmune Dis"},{"key":"820_CR31","unstructured":"The Japanese Ministry of Health, Labour and Welfare. The manual for handling disorders due to adverse drug reactions. 2010. https:\/\/www.mhlw.go.jp\/topics\/2006\/11\/dl\/tp1122-1j17.pdf (accessed on 22 Jun 2025)."},{"issue":"6","key":"820_CR32","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/jcpt.13451","volume":"46","author":"Y Akamine","year":"2021","unstructured":"Akamine Y, Fujiyama N, Kagaya H, Saito M, Miura H, Terada Y, Takahashi T, Satoh S, Miura M. Tacrolimus concentrations after renal transplantation in a mother-neonate dyad: Maternal, neonatal and breast milk measurements. J Clin Pharm Ther. 2021;46(6):1800\u20133. https:\/\/pubmed.ncbi.nlm.nih.gov\/34041772\/.","journal-title":"J Clin Pharm Ther"}],"container-title":["International Breastfeeding Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13006-026-00820-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13006-026-00820-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13006-026-00820-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:44:16Z","timestamp":1781631856000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13006-026-00820-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1186\/s13006-026-00820-1","relation":{},"ISSN":["1746-4358"],"issn-type":[{"value":"1746-4358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"5 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the Ethics Committee of Tohoku University Graduate School of Medicine (No. 2018-1-594).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}